Boston Scientific Recalls 2 Types Of Defibrillator

By Nick Malinowski

Law360, New York (March 15, 2010, 6:36 PM ET) -- Boston Scientific Corp. has announced it is recalling two defibrillator types because it failed to inform the U.S. Food and Drug Administration of manufacturing process changes.

The Natick, Mass.-based company announced that it has stopped shipping all implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, and is retrieving field inventory that has already gone out to customers.

Short-circuiting failures in unit Guidant LLC's ICDs are the focus of a U.S. Department of Justice criminal complaint accusing Guidant of concealing significant safety problems.

Boston Scientific said there...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles